Evidence-graded answer
Can GLP-1 help with alcohol or opioid use disorder?
Promising preliminary signal for both. GLP-1 acts on brain reward circuits that overlap with addiction pathways. Several RCTs in alcohol use disorder (AUD) and opioid use disorder (OUD) are underway. As of 2026, no GLP-1 is FDA-approved for any addiction indication.
Mechanism: GLP-1 reduces dopamine signaling in nucleus accumbens in response to addictive substances — same pathway implicated in food reward.
AUD: small Phase 2 trials show 30-40% reduction in heavy-drinking days. Larger NIH-funded Phase 3 trial ongoing.
OUD: very early-stage research, mostly observational. No clinical guidance yet for clinicians to prescribe GLP-1 specifically for addiction.